These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 16814737)

  • 1. Homogeneous time-resolved fluorescence and its applications for kinase assays in drug discovery.
    Jia Y; Quinn CM; Gagnon AI; Talanian R
    Anal Biochem; 2006 Sep; 356(2):273-81. PubMed ID: 16814737
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HTRF: A technology tailored for drug discovery - a review of theoretical aspects and recent applications.
    Degorce F; Card A; Soh S; Trinquet E; Knapik GP; Xie B
    Curr Chem Genomics; 2009 May; 3():22-32. PubMed ID: 20161833
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluating the utility of the HTRF Transcreener ADP assay technology: a comparison with the standard HTRF assay technology.
    Hong L; Quinn CM; Jia Y
    Anal Biochem; 2009 Aug; 391(1):31-8. PubMed ID: 19406097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative analysis of various in vitro COT kinase assay formats and their applications in inhibitor identification and characterization.
    Jia Y; Quinn CM; Clabbers A; Talanian R; Xu Y; Wishart N; Allen H
    Anal Biochem; 2006 Mar; 350(2):268-76. PubMed ID: 16356459
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current status of HTRF(®) technology in kinase assays.
    Jia Y
    Expert Opin Drug Discov; 2008 Dec; 3(12):1461-74. PubMed ID: 23506109
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and applications of a broad-coverage, TR-FRET-based kinase binding assay platform.
    Lebakken CS; Riddle SM; Singh U; Frazee WJ; Eliason HC; Gao Y; Reichling LJ; Marks BD; Vogel KW
    J Biomol Screen; 2009 Sep; 14(8):924-35. PubMed ID: 19564447
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enzyme fragment complementation binding assay for p38alpha mitogen-activated protein kinase to study the binding kinetics of enzyme inhibitors.
    Zaman GJ; van der Lee MM; Kok JJ; Nelissen RL; Loomans EE
    Assay Drug Dev Technol; 2006 Aug; 4(4):411-20. PubMed ID: 16945014
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of a time-resolved fluorescence resonance energy transfer assay for cyclin-dependent kinase 4 and identification of its ATP-noncompetitive inhibitors.
    Lo MC; Ngo R; Dai K; Li C; Liang L; Lee J; Emkey R; Eksterowicz J; Ventura M; Young SW; Xiao SH
    Anal Biochem; 2012 Feb; 421(2):368-77. PubMed ID: 22056947
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HTRF Kinase Assay Development and Methods in Inhibitor Characterization.
    Jia Y; Manuia M; Juarez J
    Methods Mol Biol; 2016; 1360():1-18. PubMed ID: 26501898
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Homogeneous proximity tyrosine kinase assays: scintillation proximity assay versus homogeneous time-resolved fluorescence.
    Park YW; Cummings RT; Wu L; Zheng S; Cameron PM; Woods A; Zaller DM; Marcy AI; Hermes JD
    Anal Biochem; 1999 Apr; 269(1):94-104. PubMed ID: 10094779
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current in vitro kinase assay technologies: the quest for a universal format.
    Jia Y; Quinn CM; Kwak S; Talanian RV
    Curr Drug Discov Technol; 2008 Mar; 5(1):59-69. PubMed ID: 18537568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A widely applicable, high-throughput TR-FRET assay for the measurement of kinase autophosphorylation: VEGFR-2 as a prototype.
    Moshinsky DJ; Ruslim L; Blake RA; Tang F
    J Biomol Screen; 2003 Aug; 8(4):447-52. PubMed ID: 14567797
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Utilization of fluorescence polarization and time resolved fluorescence resonance energy transfer assay formats for SAR studies: Src kinase as a model system.
    Newman M; Josiah S
    J Biomol Screen; 2004 Sep; 9(6):525-32. PubMed ID: 15452339
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Time-resolved fluorescence resonance energy transfer as a versatile tool in the development of homogeneous cellular kinase assays.
    Saville L; Spais C; Mason JL; Albom MS; Murthy S; Meyer SL; Ator MA; Angeles TS; Husten J
    Assay Drug Dev Technol; 2012 Dec; 10(6):551-7. PubMed ID: 22428805
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Staurosporine induces rapid homotypic intercellular adhesion of U937 cells via multiple kinase activation.
    Cho JY; Katz DR; Chain BM
    Br J Pharmacol; 2003 Sep; 140(2):269-76. PubMed ID: 12970105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of high-throughput TR-FRET and AlphaScreen assays for identification of potent inhibitors of PDK1.
    Xu Z; Nagashima K; Sun D; Rush T; Northrup A; Andersen JN; Kariv I; Bobkova EV
    J Biomol Screen; 2009 Dec; 14(10):1257-62. PubMed ID: 19822882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recommendations for the reduction of compound artifacts in time-resolved fluorescence resonance energy transfer assays.
    Imbert PE; Unterreiner V; Siebert D; Gubler H; Parker C; Gabriel D
    Assay Drug Dev Technol; 2007 Jun; 5(3):363-72. PubMed ID: 17638536
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A homogeneous time-resolved fluorescence detection of telomerase activity.
    Gabourdes M; Bourgine V; Mathis G; Bazin H; Alpha-Bazin B
    Anal Biochem; 2004 Oct; 333(1):105-13. PubMed ID: 15351286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Versatility of homogeneous time-resolved fluorescence resonance energy transfer assays for biologics drug discovery.
    Rossant CJ; Matthews C; Neal F; Colley C; Gardener MJ; Vaughan T
    J Biomol Screen; 2015 Apr; 20(4):508-18. PubMed ID: 25381254
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single-cell kinase assays: opening a window onto cell behavior.
    Sims CE; Allbritton NL
    Curr Opin Biotechnol; 2003 Feb; 14(1):23-8. PubMed ID: 12565998
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.